The Biggest Psychedelic News This Week: November 13th-17th
Policy, ResearchPsilocybin can be an useful tool when it comes to reducing nicotine withdrawal, PTSD, and even OCD symptoms. It could also be a hazardous weapon for those who suffer from personality disorders.
Personality Disorders: A Major X-Factor in Psychedelic Therapy
ResearchPsychedelics, like humans, vary in nature. A new study highlighting their imperfections is crucial to avoiding the shadows.
Wonderland Miami 2023: New Psychedelic Marvels, Practical Business Updates
Business, ResearchThe conference this year focused more on the fascinating applications of psychedelics either planned or in the works, rather than looking at the markers of a maturing industry, which was the theme of the 2022 Wonderland conference presentations.
The Biggest Psychedelic News This Week: November 6 – 10
Policy, ResearchWhile everyone was preparing to head to Wonderland Miami, the psychedelic space saw a week full of debates! From the FDA's recommendation to limit psychological support in clinical trials, to debates over the necessity of the 'trip' in the psychedelic experience, to whether microdosing's benefits are influenced by expectancy bias.
Topical Ketamine: A Game-Changer for PTSD?
Business, ResearchAnecdotal research suggests NeuroDirect topical ketamine relieves PTSD symptoms in minutes. But the mechanism of action is unclear.
Is Ibogaine & 5-MeO-DMT the ultimate 1-2 punch for PTSD? This study suggests that it might be for Special Operation Forces Veterans
ResearchThe potential benefits of combined ibogaine & 5-MeO-DMT assisted therapy include,
significant and very large improvements in self reported symptoms of PTSD, depression, anxiety, insomnia severity, and anger, a significant and medium reduction in suicidal ideation, and more.
The Biggest Psychedelic News This Week: Oct 30th – Nov 3rd
Policy, ResearchWhile unprecedented positive results provide further proof of psilocybin's anti-depressive effects, other studies investigate the long-term adverse effects of challenging trips. Meanwhile, the DEA wants to increase the manufacturing of certain psychedelics yet again as more psychedelic dispensaries are getting raided in Canada.
Africa’s Forgotten Cradle of Psychoactive Plants – Global Psychoactive Plant Use Research
Culture, ResearchDocumenting over 300 species of psychoactive plants being used for psychedelic and psychoactive purposes in African traditional medicine; the first comprehensive inventory of psychoactive plants from the continent. This includes plants with sedative, stimulant, memory enhancing and visionary entheogenic uses amongst others, for treating various conditions such as; Alzheimer's, dementia, insomnia, epilepsy, stress, anxiety and depression.
Single Dose Of Next-Gen Psilocybin Shows Significant Reduction In Depression, 20% No Longer Needing Treatment
ResearchThe interim results show remarkable and rapid reduction in depression symptoms compared to traditional antidepressants three weeks after a single dose of next-generation psilocybin.
The Biggest Psychedelic News This Week – October 23rd
ResearchAs researchers investigate the potential of psilocybin in cancer patients and LSD as treatment for ADHD, the psychedelic ecosystem witnesses more acquisitions, patents, and decriminalization efforts. However, the space also sees reprimands for abuse by therapists and a pilot attributing almost shutting off plane engines to a "nervous breakdown" caused by shrooms.